Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 4 of 4
Full-Text Articles in Entire DC Network
Copyright Vigilantism, Rachel Storch
Copyright Vigilantism, Rachel Storch
Stanford Technology Law Review
On July 6, 2011, some of the world’s largest entertainment companies, including Disney, Paramount, Warner Brothers, and Universal, as well as the MPAA and RIAA, entered into a historic agreement with the most prominent internet service providers (ISPs), including AT&T, Verizon, and Time Warner. Their agreement created the Copyright Alert System. Under the system, copyright owners will be able to inform ISPs of the IP addresses of suspected infringers, and ISPs will then act on their own to impose a graduating series of sanctions on their subscribers, up to and including slowing connection speeds or suspending Internet service. ISPs are …
Section 101 And Computer-Implemented Inventions, Robert Swanson
Section 101 And Computer-Implemented Inventions, Robert Swanson
Stanford Technology Law Review
No abstract provided.
What's The Connection Between Repeat Litigation And Patent Quality? A (Partial) Defense Of The Most Litigated Patents, Shawn Miller
What's The Connection Between Repeat Litigation And Patent Quality? A (Partial) Defense Of The Most Litigated Patents, Shawn Miller
Stanford Technology Law Review
My inspiration for the article was two articles by John Allison, Mark Lemley and Joshua Walker analyzing the characteristics and litigation success of the "most litigated patents." (Allison et al. (2009) published by the University of Pennsylvania Law Review and Allison et al. (2011) published by the Georgetown Law Journal)
Understanding the "most litigated patents" ("MLPs") is important because of the possibility James Bessen and Michael Meurer (2008) are correct that since the patent litigation surge of the 1990s the patent system has created net disincentives to innovate in most industries. The vast majority of patents are never litigated and …
Why The "Scope Of The Patent" Test Cannot Solve The Drug Patent Settlement Problem, Michael Carrier
Why The "Scope Of The Patent" Test Cannot Solve The Drug Patent Settlement Problem, Michael Carrier
Stanford Technology Law Review
No abstract provided.